124 related articles for article (PubMed ID: 16684660)
21. Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver.
Kocarek TA; Kraniak JM; Reddy AB
Mol Pharmacol; 1998 Sep; 54(3):474-84. PubMed ID: 9730906
[TBL] [Abstract][Full Text] [Related]
22. [Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice].
Grishanov AIu; Kaledin VI; Zueva TV; Nekhoroshkova EK; Nikolin VP; Liakhovich VV
Biomed Khim; 2003; 49(1):27-34. PubMed ID: 14569871
[TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacodynamics of CYP2B induction by DDT, DDE, and DDD in male rat liver and cultured rat hepatocytes.
Nims RW; Lubet RA; Fox SD; Jones CR; Thomas PE; Reddy AB; Kocarek TA
J Toxicol Environ Health A; 1998 Mar; 53(6):455-77. PubMed ID: 9537282
[TBL] [Abstract][Full Text] [Related]
24. Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver.
Fabrizi L; Gemma S; Testai E; Vittozzi L
J Biochem Mol Toxicol; 1999; 13(1):53-61. PubMed ID: 9890448
[TBL] [Abstract][Full Text] [Related]
25. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes.
Zangar RC; Novak RF
Arch Biochem Biophys; 1997 Jan; 337(2):217-24. PubMed ID: 9016816
[TBL] [Abstract][Full Text] [Related]
26. P450 enzyme CYP2B catalyzes the detoxification of diisopropyl fluorophosphate.
Laaksonen M; Kaliste-Korhonen E; Kärenlampi S; Hänninen O
Chem Biol Interact; 1995 Mar; 94(3):197-213. PubMed ID: 7820884
[TBL] [Abstract][Full Text] [Related]
27. Different profiles of hepatic alkoxyresorufin O-dealkylase activities in small rodents.
Chatuphonprasert W; Rermraksakul P; Udomsuk L; Lao-ong T; Jarukamjorn K
J Appl Toxicol; 2012 Dec; 32(12):1002-7. PubMed ID: 22610983
[TBL] [Abstract][Full Text] [Related]
28. Induction of hepatic cytochrome P450 2B and P450 3A isozymes in rats by zolazepam, a constituent of Telazol.
Wong A; Bandiera SM
Biochem Pharmacol; 1998 Jan; 55(2):201-7. PubMed ID: 9448743
[TBL] [Abstract][Full Text] [Related]
29. CAR expression and inducibility of CYP2B genes in liver of rats treated with PB-like inducers.
Pustylnyak VO; Gulyaeva LF; Lyakhovich VV
Toxicology; 2005 Dec; 216(2-3):147-53. PubMed ID: 16153763
[TBL] [Abstract][Full Text] [Related]
30. Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice.
Griffin RJ; Burka LT; Cunningham ML
Toxicol Lett; 1995 Apr; 76(3):251-6. PubMed ID: 7762012
[TBL] [Abstract][Full Text] [Related]
31. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
[TBL] [Abstract][Full Text] [Related]
32. Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism.
Li HC; Dehal SS; Kupfer D
J Biochem Toxicol; 1995 Feb; 10(1):51-61. PubMed ID: 7595932
[TBL] [Abstract][Full Text] [Related]
33. Limited in vivo bioassays on some benzodiazepines: lack of experimental initiating or promoting effect of the benzodiazepine tranquillizers diazepam, clorazepate, oxazepam and lorazepam.
Mazue G; Remandet B; Gouy D; Berthe J; Roncucci R; Williams GM
Arch Int Pharmacodyn Ther; 1982 May; 257(1):59-65. PubMed ID: 6126160
[TBL] [Abstract][Full Text] [Related]
34. Two compartment model of diazepam biotransformation in an organotypical culture of primary human hepatocytes.
Acikgöz A; Karim N; Giri S; Schmidt-Heck W; Bader A
Toxicol Appl Pharmacol; 2009 Jan; 234(2):179-91. PubMed ID: 18983865
[TBL] [Abstract][Full Text] [Related]
35. Islet antioxidant and second phase enzyme levels following CYP1A, CYP2E, CYP2B and CYP4A induction.
Clarke J; Coulter J; Flatt PR; Barnett CR
Biochem Soc Trans; 1997 Feb; 25(1):133S. PubMed ID: 9057031
[No Abstract] [Full Text] [Related]
36. Effect of phenobarbital on hepatic eicosanoid concentrations in rats.
Peebles RS; Glauert HP
Arch Toxicol; 1997; 71(10):646-50. PubMed ID: 9332702
[TBL] [Abstract][Full Text] [Related]
37. Induction of rat hepatic cytochrome P450 2B subfamily by azidophenobarbital, as a possible photoaffinity probe for the putative phenobarbital receptor: comparative study with modified phenobarbitals with different functional groups.
Shinohara T; Taura Ki; Imamura T; Yamada H; Oguri K
Drug Metab Dispos; 1997 Dec; 25(12):1442-6. PubMed ID: 9394036
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid mice.
Wolff GL; Leakey JE; Bazare JJ; Harmon JR; Webb PJ; Law MG
Carcinogenesis; 1991 May; 12(5):911-5. PubMed ID: 1674234
[TBL] [Abstract][Full Text] [Related]
39. Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium.
Catania JR; McGarrigle BP; Rittenhouse-Olson K; Olson JR
Toxicol In Vitro; 2007 Feb; 21(1):109-15. PubMed ID: 17011741
[TBL] [Abstract][Full Text] [Related]
40. Effects of benzodiazepines on enzymes metabolizing drugs. IV. Effect of diazepam and oxazepam on hepatic microsomal drug metabolizing enzymes in rats exposed to high environmental temperature.
Pachecka J; Kobylińska K; Zagdańska B; Zasłona H; Bicz W
Acta Pol Pharm; 1990; 47(1-2):23-6. PubMed ID: 12959254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
